Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Zoledronic acid
Sponsor: Chinese Academy of Medical Sciences
Collaborators: Beijing Municipal Science & Technology Commission